近日，中国科学技术大学生物医学工程学院王育才教授课题组通过体内筛选优化得到的低免疫原性LNPs，成功在体内直接编程生成耐受性抗原呈递细胞（tol-APCs），治疗自身免疫性疾病（AIDs）。相关研究成果以“Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 ...

A collaborative effort between The Wistar Institute, University of Pennsylvania, and INOVIO Pharmaceuticals has led to an ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

This eBook equips developers with essential knowledge to make informed decisions about lipid selection for LNP formulations.

A breakthrough in safely delivering therapeutic DNA to cells using lipid nanoparticles could transform treatment for millions ...

MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCalibur™, a cutting-edge, scalable nanoparticle (NP) production system in the ...

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The industry is now poised to exploit the full therapeutic potential ...

Recent legal challenges have put Moderna (NasdaqGS:MRNA) in a spotlight, as Genevant Sciences and Arbutus Biopharma Corporation have filed lawsuits alleging patent infringements related to lipid ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...